mardi 14 février 2017

Onco Actu du 14 février 2017


1. Biologie

Cold Spring Harbor scientists discover protein driver of prostate, lung cancer [FierceBiotech]

Gene editing stem cells with CRISPR could help understand brain tumours [Cancer Research UK]

3.4 Chimioprévention

GPs need help promoting the benefits of cancer preventing drugs [Cancer Research UK]

More support needed for GPs to make best use of cancer preventing drugs [Cancer Research UK]

Breast cancer pill denied to 500,000 women [The Telegraph]

Half of GPs unaware of drug's use in cancer prevention – study [The Guardian]

4. Dépistage, diagnostic et pronostic

Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs [Xconomy]

The harms of cancer screening: It’s time to get personal [HealthNewsReview]

4.9 Dép., diag. & prono. - Sein

Mammography Screening: Benefits and Potential Risks [Cancer Research Catalyst]

5. Traitements

Penis shrinkage, a side effect of prostate cancer surgery, is temporary, study finds [STAT]

Combination Therapy Improves Survival for Some Men with Recurrent Prostate Cancer [NCI]

5.2 Pharma

Can Roche's Herceptin-Perjeta combo expand yet again? Check the impending data [FiercePharma]

5.2.2 Pharma - Fusions & Acquisitions

Activists slam Immunomedics’ $2B deal with Seattle Genetics in the middle of a proxy war [EndPoints]

5.4 Traitements - Economie

NICE backs routine use of Incyte’s leukaemia drug [PharmaTimes]

Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia [NICE]

5.5 ASCO

2017 Genitourinary Cancers Symposium Kicks Off with Hot Topics [OBR blog]

In Advanced Kidney Cancer, Antibiotic Use Lowers Efficacy of Immunotherapy [ASCO]

Blood Test Uncovers Potential New Treatment Targets in Advanced Prostate Cancer [ASCO]

Some Patients Experience Long-Term Tumor Control Even After Stopping Immunotherapy Early [ASCO]

6. Lutte contre les cancers

He vowed to cure cancer. But this billionaire’s moonshot is falling far short of the hype [STAT]

Yemen cancer patients struggle to survive war shortages [Reuters]

6.10.1 Politiques (USA)

'Right to Try' is a sham [The Hill]

6.6 Publications

German scientists regain access to Elsevier journals [Nature]

Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research [JAMA]